{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T19:26:23Z","timestamp":1784575583119,"version":"3.55.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2011,10,10]],"date-time":"2011-10-10T00:00:00Z","timestamp":1318204800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0025294","type":"journal-article","created":{"date-parts":[[2011,10,10]],"date-time":"2011-10-10T20:53:44Z","timestamp":1318280024000},"page":"e25294","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":67,"title":["EBV-gp350 Confers B-Cell Tropism to Tailored Exosomes and Is a Neo-Antigen in Normal and Malignant B Cells\u2014A New Option for the Treatment of B-CLL"],"prefix":"10.1371","volume":"6","author":[{"given":"Romana","family":"Ruiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Jochum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Mocikat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Hammerschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Zeidler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,10,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-2478(96)02643-0","article-title":"B-CLL cells experimentally infected with EBV enter DNA synthesis, produce cytokines and stimulate T-lymphocytes.","volume":"54","author":"J Avila-Carino","year":"1996","journal-title":"Immunol Lett"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0165-2478(97)00142-9","article-title":"Recognition of B-CLL cells experimentally infected with EBV by autologous T lymphocytes.","volume":"60","author":"Y Tomita","year":"1998","journal-title":"Immunol Lett"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1128\/JVI.55.2.347-351.1985","article-title":"Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2).","volume":"55","author":"GR Nemerow","year":"1985","journal-title":"J Virol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.immunol.25.022106.141553","article-title":"Cellular responses to viral infection in humans: lessons from Epstein-Barr virus.","volume":"25","author":"AD Hislop","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nri2567","article-title":"Membrane vesicles as conveyors of immune responses.","volume":"9","author":"C Thery","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4049\/jimmunol.1001145","article-title":"Exosomes containing glycoprotein 350 released by EBV-transformed B cells selectively target B cells through CD21 and block EBV infection in vitro.","volume":"186","author":"H Vallhov","year":"2011","journal-title":"J Immunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nri855","article-title":"Exosomes: composition, biogenesis and function.","volume":"2","author":"C Thery","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1128\/JVI.02227-07","article-title":"Standardized and highly efficient expansion of Epstein-Barr virus (EBV)-specific CD4+ T cells using virus-like particles.","volume":"82","author":"D Adhikary","year":"2008","journal-title":"J Virol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1182\/blood-2004-03-0824","article-title":"Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells.","volume":"104","author":"AE Morelli","year":"2004","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/ni854","article-title":"Indirect activation of naive CD4+ T cells by dendritic cell-derived exosomes.","volume":"3","author":"C Thery","year":"2002","journal-title":"Nat Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.vaccine.2009.01.022","article-title":"Exosomes are an effective vaccine against congenital toxoplasmosis in mice.","volume":"27","author":"C Beauvillain","year":"2009","journal-title":"Vaccine"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.virol.2006.12.011","article-title":"Exosomal vaccines containing the S protein of the SARS coronavirus induce high levels of neutralizing antibodies.","volume":"362","author":"S Kuate","year":"2007","journal-title":"Virology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/nm0997-984","article-title":"Acquired CD40-ligand deficiency in chronic lymphocytic leukemia.","volume":"3","author":"M Cantwell","year":"1997","journal-title":"Nat Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1182\/blood.V96.9.2917","article-title":"CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia.","volume":"96","author":"WG Wierda","year":"2000","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1089\/104303401300057360","article-title":"Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenes.","volume":"12","author":"S Takahashi","year":"2001","journal-title":"Hum Gene Ther"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1182\/blood.V100.5.1655.h81702001655_1655_1661","article-title":"Efficient gene transfer of CD40 ligand into primary B-CLL cells using recombinant adeno-associated virus (rAAV) vectors.","volume":"100","author":"CM Wendtner","year":"2002","journal-title":"Blood"},{"key":"ref17","first-page":"2166","article-title":"In vivo activation of signal transducer and activator of transcription 1 after CD154 gene therapy for chronic lymphocytic leukemia is associated with clinical and immunologic response.","volume":"9","author":"TE Battle","year":"2003","journal-title":"Clin Cancer Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-0215(19970106)70:1<1::AID-IJC1>3.0.CO;2-1","article-title":"B-CLL cells with unusual properties.","volume":"70","author":"J Avila-Carino","year":"1997","journal-title":"Int J Cancer"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1182\/blood-2003-01-0182","article-title":"Expansion of CMV-specific CD8+CD45RA+CD27- T cells in B-cell chronic lymphocytic leukemia.","volume":"102","author":"WJ Mackus","year":"2003","journal-title":"Blood"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1365-2141.2004.05070.x","article-title":"Autologous cytomegalovirus-specific T cells as effector cells in immunotherapy of B cell chronic lymphocytic leukaemia.","volume":"126","author":"AP Kater","year":"2004","journal-title":"Br J Haematol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.1371\/journal.pone.0000583","article-title":"Immunodominance of lytic cycle antigens in epstein-barr virus-specific CD4+ T cell preparations for therapy.","volume":"2","author":"D Adhikary","year":"2007","journal-title":"PLoS ONE"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e1464","DOI":"10.1371\/journal.pone.0001464","article-title":"Conditional immortalization of human B cells by CD40 ligation.","volume":"3","author":"M Wiesner","year":"2008","journal-title":"PLoS ONE"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1182\/blood.V84.9.3158.3158","article-title":"The MDM2 oncogene overexpression in chronic lymphocytic leukemia and low-grade lymphoma of B-cell origin.","volume":"84","author":"T Watanabe","year":"1994","journal-title":"Blood"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1182\/blood.V99.12.4554","article-title":"Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes.","volume":"99","author":"C Korz","year":"2002","journal-title":"Blood"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/CJI.0b013e318183af26","article-title":"A polyvalent cellular vaccine induces T-cell responses against specific self-antigens overexpressed in chronic lymphocytic B-cell leukemia.","volume":"31","author":"K Kronenberger","year":"2008","journal-title":"J Immunother"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1182\/blood.V90.5.1927","article-title":"CD40 ligand induces an antileukemia immune response in vivo.","volume":"90","author":"D Dilloo","year":"1997","journal-title":"Blood"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1172\/JCI1472","article-title":"Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells.","volume":"101","author":"K Kato","year":"1998","journal-title":"J Clin Invest"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1089\/104303403764539332","article-title":"Bystander transfer of functional human CD40 ligand from gene-modified fibroblasts to B-chronic lymphocytic leukemia cells.","volume":"14","author":"E Biagi","year":"2003","journal-title":"Hum Gene Ther"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"6916","DOI":"10.1158\/1078-0432.CCR-05-0484","article-title":"Responses to human CD40 ligand\/human interleukin-2 autologous cell vaccine in patients with B-cell chronic lymphocytic leukemia.","volume":"11","author":"E Biagi","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref30","doi-asserted-by":"crossref","DOI":"10.1002\/0471143030.cb0322s30","article-title":"Isolation and characterization of exosomes from cell culture supernatants and biological fluids.","volume":"3.22","author":"C Thery","year":"2006","journal-title":"Curr Protoc Cell Biol Chapter 3: Unit"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-2362.2009.02131.x","article-title":"Relative seroprevalence of human herpes viruses in patients with chronic lymphocytic leukaemia.","volume":"39","author":"C Steininger","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1128\/JVI.65.7.3821-3828.1991","article-title":"Identification of two T-cell epitopes on the candidate Epstein-Barr virus vaccine glycoprotein gp340 recognized by CD4+ T-cell clones.","volume":"65","author":"LE Wallace","year":"1991","journal-title":"J Virol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1365-2141.2004.05225.x","article-title":"CD40 stimulation of B-cell chronic lymphocytic leukaemia cells enhances the anti-apoptotic profile, but also Bid expression and cells remain susceptible to autologous cytotoxic T-lymphocyte attack.","volume":"127","author":"AP Kater","year":"2004","journal-title":"Br J Haematol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1099\/0022-1317-36-1-59","article-title":"Characteristics of a human cell line transformed by DNA from human adenovirus type 5.","volume":"36","author":"FL Graham","year":"1977","journal-title":"J Gen Virol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1002\/eji.200324794","article-title":"Epstein-Barr virus nuclear antigen 1 evades direct immune recognition by CD4+ T helper cells.","volume":"34","author":"J Mautner","year":"2004","journal-title":"Eur J Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0022-1759(94)00239-S","article-title":"A non-isotopic, highly sensitive, fluorimetric, cell-cell adhesion microplate assay using calcein AM-labeled lymphocytes.","volume":"178","author":"F Braut-Boucher","year":"1995","journal-title":"J Immunol Methods"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0025294","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T20:21:33Z","timestamp":1593116493000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0025294"}},"subtitle":[],"editor":[{"given":"Gabriele","family":"Multhoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,10,10]]},"references-count":36,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2011,10,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0025294","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,10]]}}}